Dynavax Technologies [DVAX] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dynavax Technologies wins in 6 metrics, Haleon Plc - ADR wins in 13 metrics, with 0 ties. Haleon Plc - ADR appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dynavax Technologies Haleon Plc - ADR Better
P/E Ratio (TTM) 54.60 20.09 Haleon Plc - ADR
Price-to-Book Ratio 2.41 5.12 Dynavax Technologies
Debt-to-Equity Ratio 58.60 53.41 Haleon Plc - ADR
PEG Ratio 0.70 21.52 Dynavax Technologies
EV/EBITDA 67.07 33.35 Haleon Plc - ADR
Profit Margin (TTM) -16.67% 13.81% Haleon Plc - ADR
Operating Margin (TTM) 17.45% 22.21% Haleon Plc - ADR
EBITDA Margin (TTM) 17.45% 22.21% Haleon Plc - ADR
Return on Equity -9.28% 9.38% Haleon Plc - ADR
Return on Assets (TTM) 0.52% 4.61% Haleon Plc - ADR
Free Cash Flow (TTM) $60.16M $2.67B Haleon Plc - ADR
Dividend Yield N/A 1.63% N/A
1-Year Return -0.77% -10.25% Dynavax Technologies
Price-to-Sales Ratio (TTM) 3.76 3.65 Haleon Plc - ADR
Enterprise Value $864.93M $117.43B Haleon Plc - ADR
EV/Revenue Ratio 2.74 7.95 Dynavax Technologies
Gross Profit Margin (TTM) 85.29% 55.38% Dynavax Technologies
Revenue per Share (TTM) $3 $2 Dynavax Technologies
Earnings per Share (Diluted) $-0.45 $0.45 Haleon Plc - ADR
Beta (Stock Volatility) 1.13 0.23 Haleon Plc - ADR
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Dynavax Technologies vs Haleon Plc - ADR Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dynavax Technologies-3.77%2.48%4.33%-4.26%-13.97%-19.77%
Haleon Plc - ADR-0.22%1.58%-7.49%-10.25%-6.53%-4.45%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dynavax Technologies-0.77%-3.36%133.11%-56.89%-47.19%-82.28%
Haleon Plc - ADR-10.25%49.34%21.73%21.73%21.73%21.73%

News Based Sentiment: Dynavax Technologies vs Haleon Plc - ADR

Dynavax Technologies

News based Sentiment: MIXED

October brought conflicting signals for Dynavax Technologies, with a negative performance rating from boerse.de countered by positive analyst grades from Zacks Investment Research and a maintained 'Hold' rating. The stock also experienced a slight price decrease, creating a mixed investment narrative.

View Dynavax Technologies News Sentiment Analysis

Haleon Plc - ADR

News sentiment data is not available for Haleon Plc - ADR at this time.

Performance & Financial Health Analysis: Dynavax Technologies vs Haleon Plc - ADR

MetricDVAXHLN
Market Information
Market Cap i$1.19B$41.85B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,442,7309,907,060
90 Day Avg. Volume i1,777,7439,220,510
Last Close$9.96$9.00
52 Week Range$9.20 - $14.63$8.71 - $11.42
% from 52W High-31.92%-21.19%
All-Time High$106.60 (Nov 27, 2006)$11.42 (Jun 02, 2025)
% from All-Time High-90.66%-21.19%
Growth Metrics
Quarterly Revenue Growth0.29%-0.01%
Quarterly Earnings Growth0.64%0.33%
Financial Health
Profit Margin (TTM) i-0.17%0.14%
Operating Margin (TTM) i0.17%0.22%
Return on Equity (TTM) i-0.09%0.09%
Debt to Equity (MRQ) i58.6053.41
Cash & Liquidity
Book Value per Share (MRQ)$4.22$1.77
Cash per Share (MRQ)$5.23$0.08
Operating Cash Flow (TTM) i$76.27M$3.33B
Levered Free Cash Flow (TTM) i$43.09M$2.58B
Dividends
Last 12-Month Dividend Yield iN/A1.63%
Last 12-Month Dividend iN/A$0.17

Valuation & Enterprise Metrics Analysis: Dynavax Technologies vs Haleon Plc - ADR

MetricDVAXHLN
Price Ratios
P/E Ratio (TTM) i54.6020.09
Forward P/E i28.1721.52
PEG Ratio i0.7021.52
Price to Sales (TTM) i3.763.65
Price to Book (MRQ) i2.415.12
Market Capitalization
Market Capitalization i$1.19B$41.85B
Enterprise Value i$864.93M$117.43B
Enterprise Value Metrics
Enterprise to Revenue i2.747.95
Enterprise to EBITDA i67.0733.35
Risk & Other Metrics
Beta i1.130.23
Book Value per Share (MRQ) i$4.22$1.77

Financial Statements Comparison: Dynavax Technologies vs Haleon Plc - ADR

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)DVAXHLN
Revenue/Sales i$95.44M$3.72B
Cost of Goods Sold i$14.04M$1.66B
Gross Profit i$81.41M$2.06B
Research & Development i$16.62M$105.16M
Operating Income (EBIT) i$14.43M$471.86M
EBITDA i$24.63M$488.03M
Pre-Tax Income i$21.22M$388.27M
Income Tax i$2.50M$88.98M
Net Income (Profit) i$18.72M$299.29M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)DVAXHLN
Cash & Equivalents i$51.72M$911.36M
Total Current Assets i$815.97M$5.59B
Total Current Liabilities i$68.38M$6.42B
Long-Term Debt i$286.03M$10.30B
Total Shareholders Equity i$530.94M$21.57B
Retained Earnings i$-999.37M$36.76B
Property, Plant & Equipment i$64.14M$2.52B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)DVAXHLN
Operating Cash Flow i$-101.66MN/A
Capital Expenditures i$-3.93MN/A
Free Cash Flow i$-23.57MN/A
Debt Repayment i$-80.94MN/A
Common Stock Repurchase i$-29.47MN/A

Short Interest & Institutional Ownership Analysis

MetricDVAXHLN
Shares Short i13.77M15.71M
Short Ratio i7.271.93
Short % of Float i0.18%0.00%
Average Daily Volume (10 Day) i1,442,7309,907,060
Average Daily Volume (90 Day) i1,777,7439,220,510
Shares Outstanding i125.45M12.23B
Float Shares i100.97M8.99B
% Held by Insiders i0.01%0.00%
% Held by Institutions i0.98%0.13%

Dividend Analysis & Yield Comparison: Dynavax Technologies vs Haleon Plc - ADR

MetricDVAXHLN
Last 12-Month Dividend iN/A$0.17
Last 12-Month Dividend Yield iN/A1.63%
3-Year Avg Annual Dividend iN/A$0.11
3-Year Avg Dividend Yield iN/A0.91%
3-Year Total Dividends iN/A$0.34
Ex-Dividend DateN/AApr 25, 2025